64 related articles for article (PubMed ID: 10982757)
1. Hodgkin's disease risk is increased in patients with ulcerative colitis.
Palli D; Trallori G; Bagnoli S; Saieva C; Tarantino O; Ceroti M; d'Albasio G; Pacini F; Amorosi A; Masala G
Gastroenterology; 2000 Sep; 119(3):647-53. PubMed ID: 10982757
[TBL] [Abstract][Full Text] [Related]
2. Incidence of cancer in patients with ulcerative colitis 30 years after diagnosis (the IBSEN study).
Follin-Arbelet B; Småstuen MC; Hovde Ø; Jelsness-Jørgensen LP; Moum B
Scand J Gastroenterol; 2023; 58(11):1264-1270. PubMed ID: 37337889
[TBL] [Abstract][Full Text] [Related]
3. Risk of malignancies and chemopreventive effect of statin, metformin, and aspirin in Korean patients with ulcerative colitis: a nationwide population-based study.
Oh EH; Kim YJ; Kim M; Park SH; Kim TO; Park SH
Intest Res; 2023 Nov; ():. PubMed ID: 37939723
[TBL] [Abstract][Full Text] [Related]
4. Risk of Lymphoma in Inflammatory Bowel Disease.
Siegel CA
Gastroenterol Hepatol (N Y); 2009 Nov; 5(11):784-790. PubMed ID: 37967403
[TBL] [Abstract][Full Text] [Related]
5. Lung Involvement in Inflammatory Bowel Diseases: Shared Pathways and Unwanted Connections.
Cavalli CAM; Gabbiadini R; Dal Buono A; Quadarella A; De Marco A; Repici A; Bezzio C; Simonetta E; Aliberti S; Armuzzi A
J Clin Med; 2023 Oct; 12(19):. PubMed ID: 37835065
[TBL] [Abstract][Full Text] [Related]
6. Extraintestinal Cancers in Inflammatory Bowel Disease: A Literature Review.
Massano A; Bertin L; Zingone F; Buda A; Visaggi P; Bertani L; de Bortoli N; Fassan M; Scarpa M; Ruffolo C; Angriman I; Bezzio C; Casini V; Ribaldone DG; Savarino EV; Barberio B
Cancers (Basel); 2023 Jul; 15(15):. PubMed ID: 37568640
[TBL] [Abstract][Full Text] [Related]
7. Incidence of lymphomas in inflammatory bowel disease: report of an emblematic case, systematic review, and meta-analysis.
Russo MF; Diddoro A; Iodice A; Severi C; Castagneto-Gissey L; Casella G
Front Med (Lausanne); 2023; 10():1172634. PubMed ID: 37206474
[TBL] [Abstract][Full Text] [Related]
8. Chemoprevention of Colitis-Associated Dysplasia or Cancer in Inflammatory Bowel Disease.
Hsiao SW; Yen HH; Chen YY
Gut Liver; 2022 Nov; 16(6):840-848. PubMed ID: 35670121
[TBL] [Abstract][Full Text] [Related]
9. Primary Diffuse Large B-Cell Lymphoma of the Rectosigmoid Colon in a Patient With Ulcerative Colitis Who Never Received Immunosuppression.
Mulat BB; Boroda K; Guddati H; Kiyici N
ACG Case Rep J; 2020 Dec; 7(12):e00490. PubMed ID: 34476268
[TBL] [Abstract][Full Text] [Related]
10. Colorectal Lymphoma: A Review.
Gay ND; Chen A; Okada CY
Clin Colon Rectal Surg; 2018 Sep; 31(5):309-316. PubMed ID: 30186053
[TBL] [Abstract][Full Text] [Related]
11. Colorectal Malignancy in a Prospective Irish Inflammatory Bowel Disease Population 15 Years Since Diagnosis: Comparison with the EC-IBD Cohort.
Shuhaibar M; O'Morain C
Gastroenterol Res Pract; 2017; 2017():4946068. PubMed ID: 29147110
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up reveals high incidence of colorectal cancer in Indian patients with inflammatory bowel disease.
Bopanna S; Kedia S; Das P; Dattagupta S; Sreenivas V; Mouli VP; Dhingra R; Pradhan R; Kumar NS; Yadav DP; Makharia G; Ahuja V
United European Gastroenterol J; 2017 Aug; 5(5):708-714. PubMed ID: 28815035
[TBL] [Abstract][Full Text] [Related]
13. Worldwide Incidence of Colorectal Cancer, Leukemia, and Lymphoma in Inflammatory Bowel Disease: An Updated Systematic Review and Meta-Analysis.
Wheat CL; Clark-Snustad K; Devine B; Grembowski D; Thornton TA; Ko CW
Gastroenterol Res Pract; 2016; 2016():1632439. PubMed ID: 27293427
[TBL] [Abstract][Full Text] [Related]
14. Effect of Ulcerative Colitis on Incidence of Colorectal Cancer: Results from the Nationwide Population-Based Cohort Study (2003-2013).
Choi JK; Kim DW; Shin SY; Park EC; Kang JG
J Cancer; 2016; 7(6):681-6. PubMed ID: 27076849
[TBL] [Abstract][Full Text] [Related]
15. A population-based study examining the risk of malignancy in patients diagnosed with inflammatory bowel disease.
Wilson JC; Furlano RI; Jick SS; Meier CR
J Gastroenterol; 2016 Nov; 51(11):1050-1062. PubMed ID: 27056729
[TBL] [Abstract][Full Text] [Related]
16. Lymphoproliferative disorders in inflammatory bowel disease patients on immunosuppression: Lessons from other inflammatory disorders.
Lam GY; Halloran BP; Peters AC; Fedorak RN
World J Gastrointest Pathophysiol; 2015 Nov; 6(4):181-92. PubMed ID: 26600976
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA214 Is Associated With Progression of Ulcerative Colitis, and Inhibition Reduces Development of Colitis and Colitis-Associated Cancer in Mice.
Polytarchou C; Hommes DW; Palumbo T; Hatziapostolou M; Koutsioumpa M; Koukos G; van der Meulen-de Jong AE; Oikonomopoulos A; van Deen WK; Vorvis C; Serebrennikova OB; Birli E; Choi J; Chang L; Anton PA; Tsichlis PN; Pothoulakis C; Verspaget HW; Iliopoulos D
Gastroenterology; 2015 Oct; 149(4):981-92.e11. PubMed ID: 26055138
[TBL] [Abstract][Full Text] [Related]
18. Colorectal cancers in ulcerative colitis from a low-prevalence area for colon cancer.
Desai D; Shah S; Deshmukh A; Abraham P; Joshi A; Gupta T; Deshpande R; Khandagale V; George S
World J Gastroenterol; 2015 Mar; 21(12):3644-9. PubMed ID: 25834332
[TBL] [Abstract][Full Text] [Related]
19. Colorectal cancer surveillance in inflammatory bowel disease: A critical analysis.
Desai D; Desai N
World J Gastrointest Endosc; 2014 Nov; 6(11):541-8. PubMed ID: 25400868
[TBL] [Abstract][Full Text] [Related]
20. Intestinal cancer in inflammatory bowel disease: natural history and surveillance guidelines.
Hernández V; Clofent J
Ann Gastroenterol; 2012; 25(3):193-200. PubMed ID: 24714149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
